These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15848720

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Mycophenolic acid trough level monitoring in solid organ transplant recipients treated with mycophenolate mofetil: association with clinical outcome.
    Kaplan B.
    Curr Med Res Opin; 2006 Dec; 22(12):2355-64. PubMed ID: 17257450
    [Abstract] [Full Text] [Related]

  • 44. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine.
    Lee CM, Markezich AJ, Scandling JD, Dafoe DC, Alfrey EJ.
    J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512
    [Abstract] [Full Text] [Related]

  • 45. Alterations of cyclosporin A metabolism induced by mycophenolate mofetil.
    Pape L, Froede K, Strehlau J, Ehrich JH, Offner G.
    Pediatr Transplant; 2003 Aug; 7(4):302-4. PubMed ID: 12890009
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.
    Barten MJ, van Gelder T, Gummert JF, Boeke K, Shorthouse R, Billingham ME, Morris RE.
    Am J Transplant; 2002 Sep; 2(8):719-32. PubMed ID: 12243493
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Differential effects of mycophenolate mofetil and cyclosporine A on peripheral blood and cord blood natural killer cells activated with interleukin-2.
    Derniame S, Perazzo J, Lee F, Domogala A, Escobedo-Cousin M, Alnabhan R, Luevano M, Pedroza-Pacheco I, Cooper N, Madrigal A, Saudemont A.
    Cytotherapy; 2014 Oct; 16(10):1409-18. PubMed ID: 24969967
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients.
    Park SI, Felipe CR, Machado PG, Garcia R, Skerjanec A, Schmouder R, Tedesco-Silva H, Medina-Pestana JO.
    Braz J Med Biol Res; 2005 May; 38(5):683-94. PubMed ID: 15917949
    [Abstract] [Full Text] [Related]

  • 53. Unique effects of mycophenolate mofetil on cord blood T cells: implications for GVHD prophylaxis.
    Derniame S, Lee F, Domogala A, Madrigal A, Saudemont A.
    Transplantation; 2014 Apr 27; 97(8):870-8. PubMed ID: 24670298
    [Abstract] [Full Text] [Related]

  • 54. Therapeutic Drug Monitoring of Mycophenolic Acid as a Precision Medicine Tool for Heart Transplant Patients: Results of an Observational Pharmacokinetic Pilot Study.
    Lo Re F, Angelini J, Sponga S, Nalli C, Zucchetto A, Biasizzo J, Livi U, Baraldo M.
    Pharmaceutics; 2022 Jun 20; 14(6):. PubMed ID: 35745876
    [Abstract] [Full Text] [Related]

  • 55. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Transplantation; 2004 Apr 27; 77(8):1154-62. PubMed ID: 15114077
    [Abstract] [Full Text] [Related]

  • 56. The monitoring of immunosuppressive drugs: a pharmacodynamic approach.
    Yatscoff RW, Aspeslet LJ.
    Ther Drug Monit; 1998 Oct 27; 20(5):459-63. PubMed ID: 9780118
    [Abstract] [Full Text] [Related]

  • 57. Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation.
    Serrano M, Meneu JC, Medina E, Alfaro FJ, Martinez-Flores JA, Mora S, Morales JM, Paz Artal E, Manzanares J, Serrano A.
    Transplant Proc; 2012 Nov 27; 44(9):2622-4. PubMed ID: 23146475
    [Abstract] [Full Text] [Related]

  • 58. Mycophenolate mofetil attenuates Walker's tumor growth when used alone, but the effect is lost when associated with cyclosporine.
    Silva SL, Silva SF, Cavalcante RO, Mota RS, Carvalho RA, Moraes MO, Campos HH, Moraes ME.
    Transplant Proc; 2004 May 27; 36(4):1004-6. PubMed ID: 15194349
    [Abstract] [Full Text] [Related]

  • 59. Mycophenolate mofetil inhibits T-cell proliferation in kidney transplant recipients without lowering intracellular dGTP and GTP.
    Sankatsing SU, Prins JM, Yong SL, Roelofsen J, van Kuilenburg AB, Kewn S, Back DJ, Bemelman FJ, ten Berge IJ.
    Transpl Int; 2008 Nov 27; 21(11):1066-71. PubMed ID: 18699845
    [Abstract] [Full Text] [Related]

  • 60. Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat.
    Pally C, Tanner M, Rizvi H, Papageorgiou C, Schuurman HJ.
    Toxicology; 2001 Jan 26; 157(3):207-15. PubMed ID: 11164985
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.